Empresa Lexagene Holdings Inc Toronto S.E.
Acciones
WEY
CA52886L1031
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Genetic Analyzer
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70 % |
Ventas por región
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Jane Sykes
BRD | Director/Board Member | - | 15/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 140 740 255 | 115 621 362 ( 82,15 %) | 0 | 82,15 % |
Información de la empresa
Lexagene Holdings, Inc.
500 Cummings Center Suite 4550
01915, Beverly
+800 215 1824
http://www.lexagene.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,90 % | 9296,61 M | |
-6,25 % | 3103,28 M | |
+25,95 % | 2865,49 M | |
-13,96 % | 2169,93 M | |
-16,83 % | 1749,13 M | |
+72,82 % | 1503,65 M | |
+29,17 % | 807 M | |
-2,62 % | 759 M | |
-26,33 % | 532 M |